Corrigendum: Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer

Ítems similars

• Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer
  per: Song, Xuejiao, et al.
  Publicat: (2016)
• Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma
  per: Zhu, Yongxia, et al.
  Publicat: (2016)
• Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis
  per: Gao, Chao, et al.
  Publicat: (2016)
• A novel benzothiazole derivative YLT322 induces apoptosis via the mitochondrial apoptosis pathway in vitro with anti-tumor activity in solid malignancies.
  per: Song Xuejiao, et al.
  Publicat: (2013-01-01)
• A Novel Benzothiazole Derivative YLT322 Induces Apoptosis via the Mitochondrial Apoptosis Pathway In Vitro with Anti-Tumor Activity in Solid Malignancies
  per: Xuejiao, Song, et al.
  Publicat: (2013)